{"id":"W2763948152","doi":"","title":"Use of Obinutuzumab for B-cell Malignancies","year":2017,"lang":"en","type":"article","venue":"Medical Research Archives","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Obinutuzumab; Rituximab; CD20; Medicine; Chronic lymphocytic leukemia; Monoclonal antibody; Oncology; Monoclonal antibody therapy; Lymphoma; Monoclonal; Internal medicine; Immunology; Leukemia; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","sts"],"consensus_categories":[],"category_scores_codex":[0.002082606,0.0001559485,0.0004788385,0.0003271941,0.0005593771,0.0001129548,0.001014238,0.0001519502,0.000439729],"category_scores_gemma":[0.03448778,0.0001166017,0.0002275374,0.000116347,0.003567238,0.0001684798,0.0008712232,0.0006984145,0.00005920525],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00130836,"about_ca_system_score_gemma":0.01978661,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001040081,"about_ca_topic_score_gemma":0.00009187991,"domain_scores_codex":[0.994941,0.0002259862,0.0004153335,0.0004601342,0.002874602,0.00108293],"domain_scores_gemma":[0.9916574,0.005416507,0.000104628,0.001511638,0.000336155,0.0009736922],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01579603,0.002884797,0.008550672,0.01085477,0.0006588864,0.002402435,0.004243741,0.000009456612,0.1618613,0.02459064,0.1040113,0.6641359],"study_design_scores_gemma":[0.05904983,0.005965887,0.02408292,0.003797588,0.00009427454,0.0003590893,0.000653759,0.08165377,0.3621072,0.01315047,0.4484673,0.0006179581],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9457624,0.0009500502,0.003206881,0.006471178,0.0002140284,0.002551305,0.00008662754,0.00006403767,0.04069351],"genre_scores_gemma":[0.9729966,0.001334839,0.005310662,0.00008443576,0.0003704038,0.0002070674,0.00002563884,0.00004655916,0.01962379],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.663518,"threshold_uncertainty_score":0.9991445,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1962971642212667,"score_gpt":0.4476604100344491,"score_spread":0.2513632458131824,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}